Similar Articles
331 CK5/6-positive, P63-positive lymphoepithelioma-like hepatocellular carcinoma: A case report and literature review
332 Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
333 Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
334 Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report
335 Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
336 Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 1
337 Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
338 Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
339 Acute respiratory distress syndrome and severe pneumonitis after atezolizumab plus bevacizumab for hepatocellular carcinoma treatment: A case report
340 Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA